DongKoo Bio& Pharma

Seoul, South Korea Founded: 1970 • Age: 56 yrs
Company focused on generic medicines, OTC, stem cell extraction kits, medical apparatus, cosmetics CMO services
Request Access

About DongKoo Bio& Pharma

DongKoo Bio& Pharma is a company based in Seoul (South Korea) founded in 1970.. DongKoo Bio& Pharma offers products and services including Specialist Medicines, General Medicines, Cosmetics, and Medical Devices. DongKoo Bio& Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Seoul, South Korea
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name (주)동구바이오제약
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DongKoo Bio& Pharma

DongKoo Bio& Pharma offers a comprehensive portfolio of products and services, including Specialist Medicines, General Medicines, Cosmetics, and Medical Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Prescription drugs for skin and general treatments

Over-the-counter drugs for everyday health

Skin care products for personal wellness

Equipment for medical and diagnostic use

Funding Insights of DongKoo Bio& Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by DongKoo Bio& Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DongKoo Bio Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dongkoo Bio& Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DongKoo Bio& Pharma

DongKoo Bio& Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Contract development and manufacturing organization for proprietary and generic drugs
domain founded_year HQ Location
CDMO focusing on spectrum of dosage forms and therapeutic segments
domain founded_year HQ Location
Company offering a suite of R&D and manufacturing services for small molecules and generics
domain founded_year HQ Location
Pharmaceutical development and manufacturing services are offered contractually.
domain founded_year HQ Location
CDMO with a focus on early phase drug product development
domain founded_year HQ Location
Cephalosporin APIs and generic formulations are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about DongKoo Bio& Pharma

When was DongKoo Bio& Pharma founded?

DongKoo Bio& Pharma was founded in 1970.

Where is DongKoo Bio& Pharma located?

DongKoo Bio& Pharma is headquartered in Seoul, South Korea.

Who is the current CEO of DongKoo Bio& Pharma?

Youngjun Cho is the current CEO of DongKoo Bio& Pharma.

What does DongKoo Bio& Pharma do?

DongKoo Bio Pharma is a diversified company focused on generic medicines, OTC, stem cell extraction kits, medical apparatus, Cosmetics CMO services. The company has a strong pipeline of products in various stages of developments including clinical trials, preclinical, process validation, pilot test formulation. The company is developing medicines for dermatology, urology, circulatory system, respiratory system, neuropsychiatry system, bones, and joints. The company also offers CMO services for tablets, hard capsules, soft gelatin capsules, liquids, powder external use products. It has developed stem cell extraction kits for aesthetic surgery anti-snoring oral devices for sleep apnea. The company has products in the market such as Cenilton for prostate treatment (partnership with Cerbios-pharma), Ventux for active probiotic intestinal treatment, and Dentheth ointment for gum disease treatment. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Who are the top competitors of DongKoo Bio& Pharma?

DongKoo Bio& Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

What products or services does DongKoo Bio& Pharma offer?

DongKoo Bio& Pharma offers Specialist Medicines, General Medicines, Cosmetics, and Medical Devices.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available